基本信息:
- 专利标题： KRAS G12C INHIBITORS FOR TREATING CANCER
- 申请号：EP23182678.5 申请日：2019-06-10
- 公开(公告)号：EP4268898A2 公开(公告)日：2023-11-01
- 发明人： CHEN, Jian , TAMAYO, Nuria A. , LIU, Longbin , WANG, Hui-Ling , LANMAN, Brian Alan , WURZ, Ryan Paul , SHIN, Youngsook , CEE, Victor J.
- 申请人： Amgen Inc.
- 申请人地址： US Thousand Oaks CA 91320 One Amgen Center Drive
- 代理机构： Murgitroyd & Company
- 优先权： US201862683263 P 20180611
- 主分类号： A61P35/00
- IPC分类号： A61P35/00
摘要：
Provided herein are KRAS G12C inhibitors, such as
composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
公开/授权文献:
- EP4268898A3 KRAS G12C INHIBITORS FOR TREATING CANCER 公开/授权日：2024-01-17
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61P | 化合物或药物制剂的治疗活性 |
| ------A61P35/00 | 抗肿瘤药 |